Impact of COVID‐19 pandemic on ST‐elevation myocardial infarction in a non‐COVID‐19 epicenter

• Published in: Catheterization and cardiovascular interventions Vol. 97; no. 2; pp. 208 - 214
• Main Authors: Hammad, Tarek A., Parikh, Melanie, Tashtish, Nour, Lowry, Cynthia M., Gorbey, Diane, Forouzandeh, Farshad, Filby, Steven J., Wolf, William M., Costa, Marco A., Simon, Daniel I., Shishehbor, Mehdi H.
• Format: Journal Article
• Language: English
• Published: Hoboken, USA John Wiley & Sons, Inc 01.02.2021; Wiley Subscription Services, Inc
• Subjects: Aged; Blood pressure; Calcium-binding protein; Communicable Disease Control; Coronary Artery Disease; coronavirus; COVID-19; COVID-19 - epidemiology; delayed presentation; door‐to‐balloon; Fear; Female; Heart attacks; Heart rate; Humans; Length of Stay; Male; Middle Aged; Myocardial infarction; Ohio; Original Studies; Pandemics; Public health; Retrospective Studies; ST Elevation Myocardial Infarction - diagnosis; ST Elevation Myocardial Infarction - mortality; ST Elevation Myocardial Infarction - therapy; Survival Rate; Time-to-Treatment; Treatment Outcome; Troponin; Ventricle; Ohio; door-to-balloon; length of stay; coronavirus; delayed presentation; troponin

Objectives We sought to study the impact of COVID‐19 pandemic on the presentation delay, severity, patterns of care, and reasons for delay among patients with ST‐elevation myocardial infarction (STEMI) in a non‐hot‐spot region. Background COVID‐19 pandemic has significantly reduced the activations f...